Skin autofluorescence: Correlation with measures of diabetic sensorimotor neuropathy
Authors:
- 5 July 2018
- journal article
- research article
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 32 (9) , 851-856
Abstract
No abstract availableKeywords
Funding Information
- Woerwag Pharma Romania (2015)
This publication has 29 references indexed in Scilit:
- Variability of Skin Autofluorescence Measurement Over 6 and 12 Weeks and the Influence of Benfotiamine TreatmentDiabetes Technology & Therapeutics, 2013
- Clinical and Technical Factors Associated with Skin Intrinsic Fluorescence in Subjects with Type 1 Diabetes from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications StudyDiabetes Technology & Therapeutics, 2013
- Cross-Sectional Evaluation of Noninvasively Detected Skin Intrinsic Fluorescence and Mean Hemoglobin A1c in Type 1 DiabetesDiabetes Technology & Therapeutics, 2013
- Skin autofluorescence and risk of micro‐ and macrovascular complications in patients with Type 2 diabetes mellitus—a multi‐centre studyDiabetic Medicine, 2012
- Skin Intrinsic Fluorescence Correlates With Autonomic and Distal Symmetrical Polyneuropathy in Individuals With Type 1 DiabetesDiabetes Care, 2011
- Reference values for the Chinese population of skin autofluorescence as a marker of advanced glycation end products accumulated in tissueDiabetic Medicine, 2010
- DCCT and EDIC Studies in Type 1 Diabetes: Lessons for Diabetic Neuropathy Regarding Metabolic Memory and Natural HistoryCurrent Diabetes Reports, 2010
- Advanced glycation end products assessed by skin autofluorescence in type 1 diabetics are associated with nephropathy, but not retinopathyDiabetes & Metabolism, 2010
- Skin AutofluorescenceDiabetes Care, 2008
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993